Lack of consistent and rigorous QC is a major cause for concern..

Leveraging ADME Test Systems to De-risk CGT Studies

Learn more about challenges in gene therapy research, and how ADME test systems can be repurposed in... ..

Quality by Design Planning in ATMPs: A Guide to Selecting the Right Starting Materials

In this guide, learn how CDMOs and therapeutic firms can evaluate their needs and select the raw and... ..

Considerations When Sourcing CGT Cellular Starting Materials

Important considerations should be taken in the selection of a manufacturer to source Leukocytes/... ..

Disease State Primary Cells Bring Verification and Validation Studies Closer to Real-World Results

This white paper explores the the question of whether these “normal” cells are the best ... ..